-Hindustan Times Ranchi: Jharkhand’s bureaucrats have denied thousands of farm workers their legally mandated livelihoods under the guise of plugging leakages in the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), say activists. Earlier this month, HT reported that the ministry of rural development had cancelled 93 lakh MGNREGA job cards — of which 2.67 lakh cards were from Jharkhand — to weed out duplicates and cards corresponding to dead beneficiaries. At the...

-The Economic Times NEW DELHI: As Swachh Bharat Mission reaches the halfway mark of implementation, the Centre has decided to halve the expenditure on solid waste management, the biggest head of the cleanliness drive. The government has scaled down expenditure on solid waste management 46 per cent to Rs 20,153 crore from Rs 38,000 crore approved by the Cabinet in September 2014, when it gave its assent to the Rs 62,009-crore mission. The...

-TheWeek.in In a major decision that is likely to have wide-ranging repercussions, the Ministry of Home Affairs (MHA) has cancelled the Foreign Contribution Regulation Act (FCRA) registration of Public Health Foundation of India (PHFI), barring it from receiving foreign funds. PHFI is a public-private initiative that aims to strengthen training, research and policy development in public health. The NGO was launched by the then Prime Minister Manmohan Singh in 2006. The...

-The Telegraph New Delhi: Activists and researchers today accused the Centre of systematically curtailing the 100-day rural job scheme by not releasing funds for the payment of beneficiaries, diluting norms to avoid giving compensation and cancelling cards of genuine job-seekers. They said payments to around 10 crore poor workers were getting delayed because of the lack of funds. The Union rural development ministry denied the charges. At a news conference, Nikhil Dey of the...

-The Telegraph New Delhi: Regulatory efforts to get doctors in India to prescribe medicines only through their generic names, initiated about 15 years ago, will need to overcome legal challenges and resistance from sections of doctors and the pharmaceutical industry, experts said. Senior pharmacologists and industry analysts have also said it will be misleading to presume that prescriptions with generic names will automatically translate into lower medicine bills for patients as studies...